Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06824350 · ClinicalTrials.gov registry record · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
A NA study of Sepsis and Antibiotic Resistant Infection, sponsored by University of California, Berkeley.
- Recruiting
- Registry status
- NA
- Development phase
- 45,450
- Enrollment target
- 2
- Study locations
NCT06824350 is a NA study of Sepsis and Antibiotic Resistant Infection that is actively recruiting participants, run by University of California, Berkeley. The registered enrollment target is 45,450 participants, above the 6,060-participant average among 90 other Sepsis trials with a reported enrollment target (650% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06824350, a NA study of Sepsis and Antibiotic Resistant Infection, is actively recruiting participants, sponsored by University of California, Berkeley.
- RECRUITING
- Registry status
- NA
- Development phase
- 45,450 participants
- Enrollment target
- 2
- Study locations
Study Summary
The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will receive a passive chlorination technology for water supply treatment and a reliable supply of sodium hypochlorite disinfectant. Both intervention and treatment facilities will receive infection prevention and control messaging. The goal of the study is to evaluate the impact of the intervention on bacterial contamination of water supply, on staff hands, and on high-touch surfaces in maternity wards, and the following outcomes among facility-born neonates and their mothers: (1) gut carriage of bacterial pathogens associated with sepsis one week post-birth, (2) gut carriage of antibiotic resistant bacteria one week post-birth, and (3) symptoms of possible serious bacterial infection one week following birth.
Conditions Studied
Interventions
- DEVICE chlorination for water disinfection and surface disinfection
- BEHAVIORAL infection prevention and control messaging
Study Locations (2)
California
- University of California, Berkeley - Berkeley
Other
- Kenya Medical Research Institute - Nairobi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45,450 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06824350
The ClinicalTrials.gov registry entry for NCT06824350 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45,450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 6,060-participant average among 90 other Sepsis trials with a reported enrollment target (650% higher). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Sepsis appearing as the primary indexed condition, and to 2 interventions - of which chlorination for water disinfection and surface disinfection is the first listed.
NCT06824350 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.
Frequently Asked Questions
What is clinical trial NCT06824350 about?
NCT06824350 is a clinical study titled "Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates". The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will ...
What is the current status of trial NCT06824350?
This trial is currently recruiting. It is a NA study. The enrollment target is 45,450 participants. The study started on 2025-01-21. Estimated completion is 2027-07.
What conditions does trial NCT06824350 study?
This clinical trial studies the following conditions: Sepsis, Antibiotic Resistant Infection, Neonatal Mortality, Enteric Infections, Serious Bacterial Infection.
What interventions are being tested in trial NCT06824350?
The interventions under investigation include: chlorination for water disinfection and surface disinfection (DEVICE), infection prevention and control messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06824350?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06824350 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Evaluation of Pediatric eCART Implementation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.